Trial Profile
Effects of Telmisartan Compared With Candesartan on Ischemic Cardiovascular Events in High-Risk Hypertensive Patients: a Multi-Center, Prospective, Randomized, Open-Labeled, Blinded Endpoints Trial
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2015
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil (Primary) ; Telmisartan (Primary)
- Indications Hypertension; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms KCPS
- 29 Mar 2012 Planned End Date changed from 1 Mar 2014 to 1 Dec 2014 as reported by University Hospital Medical Information Network - Japan record.
- 22 Jun 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 05 Aug 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.